Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: The FAST survey

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue SUPPL. 3, 2004, Pages

  Wong, Wai Man ^a   Lim, Paul ^b   Wong, Benjamin Chun Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b EISAI CO LTD   (Japan)

Author keywords

Clinical practice pattern; Gastroenterologists; Gastroesophageal reflux disease; Otolaryngologists; Primary Care Physicians

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ASIA; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ESOPHAGUS PH; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEALTH SURVEY; HEARTBURN; HUMAN; MEDICAL EDUCATION; MEDICAL SPECIALIST; OTORHINOLARYNGOLOGY; PH MEASUREMENT; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS;

EID: 4544229537     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03590.x     Document Type: Conference Paper

References (27)

1. Locke GR 3rd, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County Minnesota. Gastroenterol. 1997; 112: 1448-56.
2. Agreus L, Svardsudd K, Talley NJ et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population based study. Am. J. Gastroenterol. 2001; 96: 2905-14.
3. Holtmann G. Reflux disease: the disorder of the third millennium. Eur J. Gastroenterol. Hepatol. 2001; 13: S5-11.
4. Haque M, Wyeth JW, Stace NH et al. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med. J. 2000; 113: 178-81.
5. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand. J. Gastroenterol. 1999; 231 (Suppl.): 20-8.
6. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann. Med. 1995; 27: 67-70.
7. Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand. J. Gastroenterol. 1991; 26: 73-81.
8. Jones RH, Lydeard SE, Hobbs FD et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5.
9. Frank L, Kleinman L, Ganoczy D et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilisation and quality of life. Dig. Dis. Sci. 2000; 45: 809-18.
10. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol. Ther 2000; 14: 1589-94.
11. Louis E, DeLooze D, Deprez P et al. Heartburn in Belgium: prevalence, impact on daily life, and utilisation of medical resources. Eur. J. Gastroenterol. Hepatol. 2002; 14: 279-84.
12. Sandler RS, Everhart JE, Donowitz M et al. The burden of selected digestive diseases in the Unites States. Gastroenterology 2002; 122: 1500-11.
13. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am. J. Gastroenterol. 1998; 93: 1816-22.
14. Goh KL, Chang CS, Fock KM et al. Gastro-oesophageal reflux disease in Asia. J. Gastroenterol. Hepatol. 2000; 15: 230-8.
15. Wong WM, Lai KC, Lam KF et al. Prevalence, clinical spectrum and health care utilisation of gastro-oesophageal reflux disease in Chinese population: a population-based study. Aliment Pharmacol. Ther 2003; 18: 595-604.
16. Kang JY, Tay HH, Yap I, Guan R., Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J. Clin. Gastroenterol. 1993; 16: 70-3.
17. Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am. J. Gastroenterol. 1997; 92: 668-71.
18. Yeom JS, Park HJ, Cho JS, Lee SI, Park IS. Reflux esophagitis and its relationship to hiatal hernia. J. Korean Med. Sci. 1999; 14: 253-6.
19. Wong WM, Lam SK, Hui WM et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese - prevalence and spectrum of the disease. Aliment Pharmacol. Ther 2002; 16: 2037-42.
20. Dent J, Brun J, Fendrick AM et al. An evidence-based appraisal of reflux disease management- the Genval Workshop Report. Gut 1999; 44: S1-S16.
21. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 1999; 94: 1434-42.
22. Ho KY, Lim LS, Goh WT, Lee JMJ. The prevalence of gastroesophageal reflux has increased in Asia: a longitudinal study in community. J. Gastroenterol. Hepatol. 2001; 16: A132.
23. Joseph S, Hirano I. Gastroesophageal reflux disease: diagnosis. In: Fass R, ed. GERD/Dyspepsia, 1st edn. Philadelphia, PA: Hanley & Belfus, 2004; 41-54.
24. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
25. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
26. Bytzer P, Blum AL, Herdt DD. Fast and complete control of heartburn in on-demand rabeprazole maintenance therapy in patients with nonerosive reflux disease. Gastroenterology 2003; 124: A228.
27. Bytzer P, Blum AL, Herdt DD. On-demand rabeprazole therapy provides heartburn control in long-term management of nonerosive reflux disease. Gastroenterology 2003; 124: A227.